Summary Information:
Clovis Oncology Inc. Common Stock
NASDAQ:CLVS


email
admin@troach.net
Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net

NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.


Clovis Oncology Inc. Common Stock
Exchange: NASDAQ
Symbol: CLVS
SEC CIK: 0001466301
Phone: (303) 625-5000
5500 FLATIRON PARKWAY
SUITE 100
BOULDER CO 80301
CEO: Patrick Mahaffy
Price when page updated: 0.2002 Date: 2022-12-11
Company Website:
www.clovisoncology.com

_Description: Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops, with partners, for those indications that require them, diagnostic tools intended to direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado, with additional office locations in the U.S. and Europe.

IPO YEAR:
2011
Sector:
Health Care
Industry:
Biotechnology: Pharmaceutical Preparations
ADRTSO:

MarketCap:
29020044.00
Beta:
1.39279407558446
52 Week High:
11.1
52 Week Low:
2.58
52 Week Change:
-0.35040983606557374
Short Interest:

Short Date:

Shares Outstanding:
129979097
Dividend Rate:
0
Dividend Yield:
N/A
ExDividend Date:

Latest EPS:

Latest EPS Date:
13 Oct 2022
Float:
0
return on Equity:
-50.60%
Consensus EPS:

Number Of Estimates:

EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
N/A
ttmEPS:
-2.78
Revenue:
$18.871M
Gross Profit:

Cash:

Debt:

Institution Percent:
18.10%
Revenue Percent:

Revenue Per Employee:

Insider Percent:
14.96%
Return on Assets:
-32.80%
Return on Capital:

Profit Margin:
-24.00%
Price to Sales:
2.87
Price To Book:
6.12
Short Ratio:
1.06
PE Ratio:
-1.3776153741658086
Employees:
429
1Y Guesstimate
N/A:N/A:N/A




__The following are links to various summary and news pages for
__Clovis Oncology Inc. Common Stock [ CLVS ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX




Page design by: TRoach
Page Last Updated: 2022-12-11